Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
about
The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.Clinical factors and comorbidities affecting the cost of hospital-treated COPD.Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.Economic burden of COPD in a Swedish cohort: the ARCTIC study.The annual direct costs of stable COPD in Greece.Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.Asymptomatic COPD, until you take it to exertion.'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in JapanPeriodontal status and lung function decline in the community: the Hisayama studyThe physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam
P2860
Q33703952-84A0A1ED-6516-4E99-9FD9-FC06B65585F9Q37485333-A9E8FDFD-478A-4B31-9D35-CAFCCD64DCA5Q37496443-C0EB4DDF-A6A2-4016-8BD3-622381A20897Q40074756-8D86280A-4B47-4053-8BAC-7471285F8E9AQ47128813-C53F9070-B7DF-4DA8-A34C-FA4FE476111EQ47637962-878F0EB7-73C4-4AEB-BDD4-39D2511A59D7Q49337347-0A8A3238-EE78-4A03-9929-B18FABC73D0FQ52674908-3EB5CCBF-72F8-429C-B06F-5071099717D8Q53785110-0C2FC972-2376-4F40-9250-3443BB5C92B2Q55007112-49845A49-388A-4991-A9E8-860ACDB967A7Q55432750-BA1AB0F3-B145-4923-84B8-728F74C24ABFQ58698628-3857C22A-E220-4ACB-A75D-F9D748425ECDQ58761875-9110BF71-4587-49E0-9E30-7C37201CAC53Q58791040-E787F664-C58E-41F1-A01A-CF2AC0136177
P2860
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@ast
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@en
type
label
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@ast
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@en
prefLabel
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@ast
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@en
P2093
P2860
P1433
P1476
Continuing to Confront COPD In ...... mpact of COPD in 12 Countries.
@en
P2093
Joe Maskell
Masakazu Ichinose
MeiLan K Han
Sarah H Landis
Thys van der Molen
Yeon-Mok Oh
Yogesh Punekar
P2860
P304
P356
10.1371/JOURNAL.PONE.0152618
P407
P577
2016-04-19T00:00:00Z